Pierre Rémy
Fondateur chez Keensight Capital SAS
Profil
Pierre Rémy is the founder of Keensight Capital SAS, which was founded in 2013.
He is currently the Chairman of Biovian Oy and a Director at LDR Spine USA, Inc. He previously held positions as a Director at LDR Holding Corp.
and a Member-Supervisory Board at Crossject SA. He will serve as a Member-Supervisory Board at Unifin SAS from 2019 to 2023.
Mr. Rémy holds an MBA from Sciences Po and a graduate degree from Arts Et Metiers Paristech.
Postes actifs de Pierre Rémy
| Sociétés | Poste | Début |
|---|---|---|
Keensight Capital SAS
 Keensight Capital SAS Investment ManagersFinance Keensight Capital SAS (Keensight) is an independent French venture capital firm which was established in 2001. Formerly known as R Capital Management SAS, a subsidiary of the Rothschild Group, the firm became independent in 2013 and changed their name to Keensight Capital. Keensight is located in Paris and manages venture capital investments, including the FCPR R Capital Technologies for a range of clients including European banks, pension schemes, insurance companies, government-controlled entities, fund of funds, family offices and high-net worth private individuals. | Fondateur | 01/11/2013 |
LDR Spine USA, Inc.
 LDR Spine USA, Inc. Medical SpecialtiesHealth Technology LDR Spine USA, Inc. offers sterile spinal implant systems. Its product line which includes pre-sterilized fusion devices help in ensuring simple and reliable management of spinal implants. The company was founded in December 1999 and is headquartered in Austin, TX. | Directeur/Membre du Conseil | - |
Biovian Oy
 Biovian Oy Pharmaceuticals: MajorHealth Technology Biovian Oy provides contract manufacturing and development of biopharmaceuticals. Its services include microbial production, mammalian production, viral vector production, aseptic fill & finish and cell banking and storage. The company was founded in 2003 and is headquartered in Turku, Finland. | Président | - |
Anciens postes connus de Pierre Rémy
| Sociétés | Poste | Fin |
|---|---|---|
Unifin SAS
 Unifin SAS Medical SpecialtiesHealth Technology Unifin SAS operates as an investment holding company which engages in pharmaceutical products and services. The company was founded on December 20, 2016 and is headquartered in Paris, France. | Directeur/Membre du Conseil | 16/04/2023 |
| LDR HOLDING CORP | Directeur/Membre du Conseil | - |
| CROSSJECT | Directeur/Membre du Conseil | - |
Formation de Pierre Rémy
| Sciences Po | Masters Business Admin |
| Arts Et Metiers Paristech | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CROSSJECT | Health Technology |
| Entreprise privées | 5 |
|---|---|
LDR Spine USA, Inc.
LDR Spine USA, Inc. Medical SpecialtiesHealth Technology LDR Spine USA, Inc. offers sterile spinal implant systems. Its product line which includes pre-sterilized fusion devices help in ensuring simple and reliable management of spinal implants. The company was founded in December 1999 and is headquartered in Austin, TX. | Health Technology |
LDR Holding Corp.
 LDR Holding Corp. Medical SpecialtiesHealth Technology LDR Holding Corp. is a medical device company, which engages on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. Its products include VerteBRIDGE fusion and Mobi non-fusion platforms. The company was founded by Christophe Lavigne, Herve Dinville and Patrick Richard in 2000 and is headquartered in Warsaw, IN. | Health Technology |
Keensight Capital SAS
Keensight Capital SAS Investment ManagersFinance Keensight Capital SAS (Keensight) is an independent French venture capital firm which was established in 2001. Formerly known as R Capital Management SAS, a subsidiary of the Rothschild Group, the firm became independent in 2013 and changed their name to Keensight Capital. Keensight is located in Paris and manages venture capital investments, including the FCPR R Capital Technologies for a range of clients including European banks, pension schemes, insurance companies, government-controlled entities, fund of funds, family offices and high-net worth private individuals. | Finance |
Biovian Oy
Biovian Oy Pharmaceuticals: MajorHealth Technology Biovian Oy provides contract manufacturing and development of biopharmaceuticals. Its services include microbial production, mammalian production, viral vector production, aseptic fill & finish and cell banking and storage. The company was founded in 2003 and is headquartered in Turku, Finland. | Health Technology |
Unifin SAS
Unifin SAS Medical SpecialtiesHealth Technology Unifin SAS operates as an investment holding company which engages in pharmaceutical products and services. The company was founded on December 20, 2016 and is headquartered in Paris, France. | Health Technology |
